FDA approves Cobenfy (Picture credit: Reuters/Bristol Myers Squibb) The US Food and Drug Administration (FDA) has approved Bristol Myers Squibb’s new oral medicine, Cobenfy, for the treatment of schizophrenia in…
FDA approves Cobenfy (Picture credit: Reuters/Bristol Myers Squibb) The US Food and Drug Administration (FDA) has approved Bristol Myers Squibb’s new oral medicine, Cobenfy, for the treatment of schizophrenia in…
NEW DELHI: Researchers from Banaras Hindu University (BHU) have conducted a one-year follow-up study on individuals who received Bharat Biotech's Covaxin. The study revealed that approximately one-third of the participants…